These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 38555115)

  • 21. Prescription Drug and Alcohol Use Disorders: Alcohol Use Disorder.
    Warren D
    FP Essent; 2019 Mar; 478():30-42. PubMed ID: 30844223
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacotherapy for alcohol dependence: status of current treatments.
    Franck J; Jayaram-Lindström N
    Curr Opin Neurobiol; 2013 Aug; 23(4):692-9. PubMed ID: 23810221
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recent Developments in Pharmacotherapy of Alcoholism.
    Soyka M; Lieb M
    Pharmacopsychiatry; 2015 Jul; 48(4-5):123-35. PubMed ID: 25761458
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnosis and Pharmacotherapy of Alcohol Use Disorder: A Review.
    Kranzler HR; Soyka M
    JAMA; 2018 Aug; 320(8):815-824. PubMed ID: 30167705
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Advances in Pharmacotherapy Development: Human Clinical Studies.
    Litten RZ; Falk DE; Ryan ML; Fertig J; Leggio L
    Handb Exp Pharmacol; 2018; 248():579-613. PubMed ID: 29294197
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The pharmacologic treatment of the alcohol dependence].
    Castro LA; Baltieri DA
    Braz J Psychiatry; 2004 May; 26 Suppl 1():S43-6. PubMed ID: 15729444
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Medications for the Treatment of Alcohol Dependence-Current State of Knowledge and Future Perspectives from a Public Health Perspective.
    Stokłosa I; Więckiewicz G; Stokłosa M; Piegza M; Pudlo R; Gorczyca P
    Int J Environ Res Public Health; 2023 Jan; 20(3):. PubMed ID: 36767234
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Medication Development for Alcohol Use Disorder: A Focus on Clinical Studies.
    Leggio L; Falk DE; Ryan ML; Fertig J; Litten RZ
    Handb Exp Pharmacol; 2020; 258():443-462. PubMed ID: 31628604
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological treatment of alcohol dependence: target symptoms and target mechanisms.
    Heilig M; Egli M
    Pharmacol Ther; 2006 Sep; 111(3):855-76. PubMed ID: 16545872
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The state of pharmacotherapy for the treatment of alcohol dependence.
    Garbutt JC
    J Subst Abuse Treat; 2009 Jan; 36(1):S15-23; quiz S24-5. PubMed ID: 19062347
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of alcohol dependence: recent progress and reduction of consumption.
    Testino G; Leone S; Borro P
    Minerva Med; 2014 Dec; 105(6):447-66. PubMed ID: 25392958
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk of hospitalisation and death related to baclofen for alcohol use disorders: Comparison with nalmefene, acamprosate, and naltrexone in a cohort study of 165 334 patients between 2009 and 2015 in France.
    Chaignot C; Zureik M; Rey G; Dray-Spira R; Coste J; Weill A
    Pharmacoepidemiol Drug Saf; 2018 Nov; 27(11):1239-1248. PubMed ID: 30251424
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sodium oxybate: a review of its use in alcohol withdrawal syndrome and in the maintenance of abstinence in alcohol dependence.
    Keating GM
    Clin Drug Investig; 2014 Jan; 34(1):63-80. PubMed ID: 24307430
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An overview of the development of medications including novel anticonvulsants for the treatment of alcohol dependence.
    Johnson BA
    Expert Opin Pharmacother; 2004 Sep; 5(9):1943-55. PubMed ID: 15330732
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alcohol Use Disorder: The Role of Medication in Recovery.
    Mason BJ; Heyser CJ
    Alcohol Res; 2021; 41(1):07. PubMed ID: 34113531
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Integration of pharmacotherapy for alcohol use disorder treatment in primary care settings: A scoping review.
    Hyland CJ; McDowell MJ; Bain PA; Huskamp HA; Busch AB
    J Subst Abuse Treat; 2023 Jan; 144():108919. PubMed ID: 36332528
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trends in the Use of Naltrexone for Addiction Treatment among Alcohol Use Disorder Admissions in U.S. Substance Use Treatment Facilities.
    Qeadan F; Mensah NA; Gu LY; Madden EF; Venner KL; English K
    Int J Environ Res Public Health; 2021 Aug; 18(16):. PubMed ID: 34444639
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sodium oxybate plus nalmefene for the treatment of alcohol use disorder: A case series.
    Caputo F; Maremmani AG; Addolorato G; Domenicali M; Zoli G; D'Amore A; Maremmani I; Bernardi M
    J Psychopharmacol; 2016 Apr; 30(4):402-9. PubMed ID: 26860331
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacotherapies for Adults With Alcohol Use Disorders: A Systematic Review and Network Meta-analysis.
    Bahji A; Bach P; Danilewitz M; Crockford D; Devoe DJ; El-Guebaly N; Saitz R
    J Addict Med; 2022 Nov-Dec 01; 16(6):630-638. PubMed ID: 35653782
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quadruple pharmacotherapy for alcohol use disorder tolerable yet insufficient: a case report.
    Terasaki D; Ellinwood A; White D
    Subst Abuse Treat Prev Policy; 2024 Feb; 19(1):18. PubMed ID: 38424567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.